Just thinking things out Junebug. We recently had an MJ company up-list to the New York Stock Exchange in just a single move. And, that company does not have what we now believe we have. If I recall, the revenue stream was only around 14 million dollars, no FDA approval, no federal contracts, and no chance of becoming federally approved to grow, process, and supply medical grade cannabis suitable for research purposes. So why would we be any different?